Novo Nordisk B A/S (NVO) released a profit for its first quarter that Increases, from last year
The company's bottom line came in at DKK48.557 billion, or DKK10.91 per share. This compares with DKK29.034 billion, or DKK6.53 per share, last year.
Excluding items, Novo Nordisk B A/S reported adjusted earnings of DKK29.479 billion or DKK6.63 per share for the period.
The company's revenue for the period rose 24.0% to DKK96.823 billion from DKK78.087 billion last year.
Novo Nordisk B A/S earnings at a glance (GAAP) :
-Earnings: DKK48.557 Bln. vs. DKK29.034 Bln. last year.-EPS: DKK10.91 vs. DKK6.53 last year.-Revenue: DKK96.823 Bln vs. DKK78.087 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.